Can you provide the average price target for TNL MEDIAGENE stock?
7 analysts have analysed TNMG and the average price target is 14.28 USD. This implies a price increase of 990.08% is expected in the next year compared to the current price of 1.31.
TNL MEDIAGENE (TNMG) Forecast, Price Target & Analyst Ratings
NASDAQ:TNMG • KYG8924F1211
Current stock price
1.31 USD
-0.18 (-12.08%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TNL MEDIAGENE (TNMG).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2025
- EPS Estimate
- -$0.06
- Revenue Estimate
- 27.849M
Price Target Details & History
Consensus Price Target and Range
Mean target
$14.28
Upside
+ 990.08%
From current price of $1.31 to mean target of $14.28, Based on 7 analyst forecasts
Low
$14.14
Median
$14.28
High
$14.70
Price Target Revisions
1 Month
0.00%
3 Months
300.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for TNMG. The average price target is 14.28 USD. This implies a price increase of 990.08% is expected in the next year compared to the current price of 1.31.
The average price target has been revised upward by 300% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
TNMG was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TNMG.
In the previous month the buy percentage consensus was at a similar level.
TNMG was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-15 | Benchmark | Maintains | Speculative Buy -> Speculative Buy |
| 2025-05-20 | Benchmark | Initiate | Speculative Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2025
- EPS Estimate
- -$0.06
- Revenue Estimate
- 27.849M
- Revenue Q2Q
- -42.57%
- EPS Q2Q
- N/A
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 35.839M | 48.494M 35.31% | 50.069M 3.25% | 56.004M 11.85% | ||
| EBITDA YoY % growth | N/A | -4.262M | -44.078M -934.30% | -3.353M 92.39% | -12.24K 99.63% | |
| EBIT YoY % growth | -1.24M -490.48% | -7.097M -472.35% | -47.318M -566.72% | -7.716M 83.69% | -2.456M 68.18% | |
| Operating Margin | N/A | -19.80% | -97.58% | -15.41% | -4.38% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.21 | -0.14 33.33% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.06 | -0.06 94.00% | -0.08 -33.33% |
| Revenue Q2Q % growth | 27.849M -42.57% | 25.554M 17.30% | 32.04M 15.05% |
| EBITDA Q2Q % growth | 100.00% | 112.2K 102.80% | -511.02K |
| EBIT Q2Q % growth | -1.965M 95.85% | -485.52K 91.39% | 471.24K 123.99% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TNL MEDIAGENE / TNMG Forecast FAQ
What are the consensus estimates for TNL MEDIAGENE (TNMG) next earnings?
The consensus EPS estimate for the next earnings of TNL MEDIAGENE (TNMG) is -0.06 USD and the consensus revenue estimate is 27.85M USD.
What is the consensus rating for TNL MEDIAGENE (TNMG) stock?
The consensus rating for TNL MEDIAGENE (TNMG) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.